Lamb Weston
LW NYSE Packaged Foods & Meats Financials FY2017βFY2026
Lamb Weston's revenue rose 2.5% to $6.6 billion in fiscal 2026. Its operating margin was 8.9%, down from 10.3% a year earlier. Free cash flow was $540 million, up 134.8%. It paid out $208 million in dividends and buybacks, 38% of free cash flow. The diluted share count fell 2.5%.
What Lamb Weston does
No business description yet.
- Legal name
- LAMB WESTON HOLDINGS, INC.
- Fiscal year ends
- May 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001679273-26-000026
0001679273
Revenue and margins
Lamb Weston had $6.6B of revenue in fiscal 2026, up 2.5% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew β0.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $540M in fiscal 2026, 8.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lamb Weston returned $208M to shareholders in fiscal 2026, 38% of free cash flow. The diluted share count fell 2.5%.
Value Lamb Weston yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$3.9B and divides by 139.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 29.4x Β· peers 18.8x Β· sector 24.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably Lamb Weston can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $525M | $305M | $71.4M | $70.7M | $68.2M |
| Debt incl. finance leases | $2.7B | $3.5B | $4.2B | $4.1B | $3.9B |
| Net debt / EBITDA | 3.5x | 2.9x | 3.0x | 3.9x | 3.9x |
| Debt / equity | 7.6x | 2.5x | 2.3x | 2.4x | 2.2x |
| Interest coverage | 5.5x | 5.8x | 5.6x | 3.2x | 2.9x |
| Current ratio | 2.4x | 1.6x | 1.3x | 1.4x | 1.4x |
| Quick ratio | 1.6x | 0.9x | 0.6x | 0.7x | 0.7x |
| Total assets | $4.1B | $6.5B | $7.4B | $7.4B | $7.4B |
| Total liabilities | $3.8B | $5.1B | $5.6B | $5.7B | $5.6B |
| Shareholders' equity | $361M | $1.4B | $1.8B | $1.7B | $1.8B |
| Net debt (β = net cash) | $2.2B | $3.2B | $4.1B | $4.1B | $3.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$19.4M
5 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 11, 2026 | James D GrayChief Financial Officer | Bought | 10,000 | $40.92 | $0.4M | Form 4 |
| Apr 27, 2026 | James D GrayChief Financial Officer | Bought | 4,556 | $43.85 | $0.2M | Form 4 |
| Apr 15, 2026 | JANA Partners Management LPDirector | Bought | 50,000 | $43.19 | $2.2M | Form 4 |
| Apr 13, 2026 | JANA Partners Management LPDirector | Bought | 100,000 | $42.12 | $4.2M | Form 4 |
| Apr 8, 2026 | JANA Partners Management LPDirector | Bought | 100,000 | $41.41 | $4.1M | Form 4 |
| Apr 7, 2026 | JANA Partners Management LPDirector | Bought | 136,000 | $40.89 | $5.6M | Form 4 |
| Apr 7, 2026 | Norman PrestageDirector | Bought | 2,500 | $41.40 | $0.1M | Form 4 |
| Apr 6, 2026 | Peter J BensenDirector | Bought | 5,000 | $39.45 | $0.2M | Form 4 |
| Feb 6, 2026 | Jan Eli B CrapsExecutive Chair, Director | Bought | 50,000 | $48.65 | $2.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | β1.1% | β6.9% | β8.8% |
| Altman Z'' | 2.92 | 2.68 | 2.71 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Lamb Weston LW | $7.4B | 2.5% | 8.9% | 8.2% | 7.1% | 29.4x | 7 | |
| McCormick MKC | $13.0B | 1.7% | 15.7% | 10.8% | 8.7% | 8.7x | 6 | Compare β |
| Post POST | $4.1B | 3.0% | 9.8% | 6.0% | 5.7% | 14.7x | 4 | Compare β |
| Flowers Foods FLO | $1.3B | 3.0% | 3.3% | 6.1% | 4.6% | 22.8x | 5 | Compare β |
| J.M. Smucker SJM | β | 3.7% | 4.0% | 12.8% | 2.2% | 60.7x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.2B | $3.4B | $3.8B | $3.8B | $3.7B | $4.1B | $5.4B | $6.5B | $6.5B | $6.6B |
| Gross profit | $779M | $880M | $1.0B | $895M | $832M | $832M | $1.4B | $1.8B | $1.4B | $1.4B |
| Research and development | $10.6M | $13.5M | $15.4M | $15.4M | $12.9M | $16.2M | $17.2M | $26.4M | $22.0M | $18.9M |
| Operating income | $518M | $580M | $668M | $557M | $475M | $444M | $882M | $1.1B | $665M | $591M |
| Interest expense | $48.8M | $104M | $108M | $106M | $121M | $80.6M | $152M | $191M | $211M | $203M |
| Pretax income | $510M | $555M | $621M | $478M | $408M | $273M | $1.2B | $956M | $500M | $418M |
| Income tax | $170M | $121M | $134M | $112M | $90.5M | $71.8M | $225M | $230M | $143M | $128M |
| Net income | $327M | $417M | $479M | $366M | $318M | $201M | $1.0B | $726M | $357M | $290M |
| Diluted EPS | $2.22 | $2.82 | $3.18 | $2.49 | $2.16 | $1.38 | $6.95 | $4.98 | $2.50 | $2.08 |
| Diluted shares | 0.15B | 0.15B | 0.15B | 0.15B | 0.15B | 0.15B | 0.15B | 0.15B | 0.14B | 0.14B |
| Cash flow | ||||||||||
| Cash from operations | $447M | $481M | $681M | $574M | $553M | $419M | $762M | $798M | $868M | $943M |
| Capital expenditure | $287M | $307M | $334M | $168M | $147M | $290M | $654M | $930M | $638M | $403M |
| Free cash flow | $160M | $174M | $347M | $406M | $406M | $129M | $108M | β$131M | $230M | $540M |
| Depreciation and amortization | $109M | $143M | $162M | $182M | $188M | $192M | $223M | $307M | $375M | $397M |
| Stock-based compensation | $5.7M | $13.5M | $18.8M | $22.8M | $20.6M | $21.3M | $38.5M | $46.8M | $39.5M | $46.2M |
| Acquisitions | $0.0M | $0.0M | $88.6M | $117M | $0.0M | $0.0M | $0.0M | $10.5M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $27.4M | $110M | $113M | $121M | $135M | $138M | $146M | $174M | $207M | $208M |
| Dividends and buybacks | $27.4M | $110M | $113M | $121M | $135M | $138M | $146M | $174M | $207M | $208M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $57.1M | $55.6M | $12.2M | $1.4B | $784M | $525M | $305M | $71.4M | $70.7M | $68.2M |
| Total debt | $2.4B | $2.4B | $2.3B | $3.5B | β | $2.7B | $3.5B | $4.2B | $4.1B | $3.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $13.3M | $7.3M | $7.0M | $7.7M | $5.7M | $5.2M | $4.0M |
| Current assets | $858M | $930M | $962M | $2.3B | $1.8B | $1.7B | $2.1B | $2.1B | $2.0B | $2.0B |
| Current liabilities | $555M | $519M | $553M | $1.0B | $618M | $699M | $1.4B | $1.6B | $1.5B | $1.4B |
| Inventory | $525M | $550M | $498M | $487M | $514M | $574M | $932M | $1.1B | $1.0B | $969M |
| Property and equipment, net | $1.3B | $1.4B | $1.6B | $1.5B | $1.5B | $1.6B | $2.8B | $3.6B | $3.7B | $3.7B |
| Total assets | $2.5B | $2.8B | $3.0B | $4.7B | $4.2B | $4.1B | $6.5B | $7.4B | $7.4B | $7.4B |
| Total liabilities | $3.1B | $3.1B | $3.1B | $4.4B | $3.7B | $3.8B | $5.1B | $5.6B | $5.7B | $5.6B |
| Shareholders' equity | β$647M | β$335M | β$4.6M | $240M | $481M | $361M | $1.4B | $1.8B | $1.7B | $1.8B |
| Margins | ||||||||||
| Gross margin | 24.6% | 25.7% | 26.7% | 23.6% | 22.7% | 20.3% | 26.8% | 27.3% | 21.7% | 20.6% |
| Operating margin | 16.4% | 16.9% | 17.8% | 14.7% | 12.9% | 10.8% | 16.5% | 16.5% | 10.3% | 8.9% |
| EBITDA margin | 19.8% | 21.1% | 22.1% | 19.5% | 18.1% | 15.5% | 20.7% | 21.2% | 16.1% | 14.9% |
| Net margin | 10.3% | 12.2% | 12.7% | 9.7% | 8.7% | 4.9% | 18.9% | 11.2% | 5.5% | 4.4% |
| FCF margin | 5.0% | 5.1% | 9.2% | 10.7% | 11.1% | 3.1% | 2.0% | β2.0% | 3.6% | 8.2% |
| Returns | ||||||||||
| Return on capital | 21.4% | 24.4% | 24.4% | 18.0% | β | β | 20.2% | 15.5% | 8.1% | 7.1% |
| Return on capital employed | 28.2% | 27.9% | 28.3% | 18.2% | 13.1% | 12.6% | 20.5% | 19.5% | 11.4% | 10.0% |
| Return on equity | 86.8% | β | β | β | 88.2% | 47.8% | 113.9% | 45.4% | 20.3% | 16.3% |
| Return on assets | 14.1% | 15.9% | 16.5% | 9.5% | 7.2% | 4.8% | 18.9% | 10.5% | 4.8% | 3.9% |
| Growth | ||||||||||
| Revenue growth | 5.8% | 8.1% | 9.7% | 1.0% | β3.2% | 11.7% | 30.5% | 20.9% | β0.3% | 2.5% |
| Net income growth | 14.6% | 27.5% | 14.8% | β23.6% | β13.2% | β36.8% | 402.2% | β28.1% | β50.8% | β18.8% |
| EPS growth | 15.6% | 27.0% | 12.8% | β21.7% | β13.3% | β36.1% | 403.6% | β28.4% | β49.8% | β16.8% |
| FCF growth | β30.7% | 9.3% | 98.8% | 17.2% | β0.2% | β68.3% | β16.2% | β221.9% | β | 134.8% |
| Share count change | 0.4% | 0.3% | 0.2% | β0.1% | 0.0% | β0.8% | β0.5% | 0.3% | β2.0% | β2.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.8x | 3.2x | 2.8x | 2.9x | β | 3.5x | 2.9x | 3.0x | 3.9x | 3.9x |
| Debt / equity | β | β | β | 14.8x | β | 7.6x | 2.5x | 2.3x | 2.4x | 2.2x |
| Interest coverage | 10.6x | 5.6x | 6.2x | 5.3x | 3.9x | 5.5x | 5.8x | 5.6x | 3.2x | 2.9x |
| Current ratio | 1.6x | 1.8x | 1.7x | 2.3x | 2.9x | 2.4x | 1.6x | 1.3x | 1.4x | 1.4x |
| Quick ratio | 0.6x | 0.7x | 0.8x | 1.8x | 2.1x | 1.6x | 0.9x | 0.6x | 0.7x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 9.1% | 9.0% | 8.9% | 4.4% | 4.0% | 7.1% | 12.2% | 14.4% | 9.9% | 6.1% |
| Stock comp / revenue | 0.2% | 0.4% | 0.5% | 0.6% | 0.6% | 0.5% | 0.7% | 0.7% | 0.6% | 0.7% |
| Payouts / FCF | 17.2% | 63.2% | 32.7% | 29.9% | 33.4% | 107.7% | 135.7% | β | 89.9% | 38.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 6.0 | 5.0 | β | β | 7.0 | 5.0 | 6.0 | 7.0 |
| Altman Z'' | 2.1 | 2.8 | 3.2 | 3.4 | 3.7 | 3.4 | 3.1 | 2.9 | 2.7 | 2.7 |
| Accruals ratio | β5.2% | β2.5% | β7.0% | β5.4% | β5.3% | β5.2% | 4.6% | β1.1% | β6.9% | β8.8% |
Source: SEC EDGAR XBRL filings (CIK 0001679273). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.